D. Sharma
Directeur Général chez Silq Technologies Corp.
Profil
Mr. D.
V.
Sharma is a Chief Executive Officer & Director at Silq Technologies Corp.
He is on the Board of Directors at Silq Technologies Corp., Biovision AG and Black Light Surgical, Inc. Mr. Sharma was previously employed as a Chairman & Chief Executive Officer by Calhoun Vision, Inc., a Vice President-Business Development by Southeast Fuels, Inc., a Principal by DVS Consulting LLC, a President & Chief Executive Officer by Cosmetic Laser Eye & Refractive Centers of America LLC, and a President & Chief Operating Officer by Summit Technology, Inc. He also served on the board at Astora Women's Health, Inc.
Postes actifs de D. Sharma
| Sociétés | Poste | Début |
|---|---|---|
| Biovision AG | Directeur/Membre du Conseil | - |
Black Light Surgical, Inc.
 Black Light Surgical, Inc. Packaged SoftwareTechnology Services Black Light Surgical, Inc. has developed breakthrough technology to revolutionize medical imaging, based on years of research at Cedars-Sinai Medical Center. The company is based in Sunny Isles Beach, FL. The technology incorporates principles of auto-fluorescence lifetime and time-resolved auto-fluorescence spectroscopy, which can be used intra-operatively and is highly accurate in characterizing tissue without the need for dyes or drugs. The company's initial focus is on addressing the long-standing problem of breast cancer, where one-third of patients require a second or third procedure following breast conserving surgery (BCS) to fully remove the cancer. | Directeur/Membre du Conseil | - |
| Silq Technologies Corp. | Directeur Général | 01/06/2020 |
Anciens postes connus de D. Sharma
| Sociétés | Poste | Fin |
|---|---|---|
| RXSIGHT, INC. | Directeur Général | 01/01/2015 |
Southeast Fuels, Inc.
 Southeast Fuels, Inc. Engineering & ConstructionIndustrial Services Southeast Fuels, Inc. markets industrial and utility coal. It supports industrial and utility users of fuel combustion products such as coal, fuel oil and natural gas. The company was founded by Ralph K. Shelton on November 3, 1984 and is headquartered in Greensboro, NC. | Corporate Officer/Principal | 01/12/2007 |
| Cosmetic Laser Eye & Refractive Centers of America LLC | President | 01/01/2003 |
| Summit Technology, Inc. | President | 01/01/2000 |
| DVS Consulting LLC | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| RXSIGHT, INC. | Electronic Technology |
| Entreprise privées | 8 |
|---|---|
Astora Women's Health, Inc.
 Astora Women's Health, Inc. Medical SpecialtiesHealth Technology Astora Women's Health, Inc. engages in the provision of pelvic health solutions. The company was founded by Dr. Brantley Scott in 1972 and is headquartered in Minnetonka, MN. | Health Technology |
Southeast Fuels, Inc.
Southeast Fuels, Inc. Engineering & ConstructionIndustrial Services Southeast Fuels, Inc. markets industrial and utility coal. It supports industrial and utility users of fuel combustion products such as coal, fuel oil and natural gas. The company was founded by Ralph K. Shelton on November 3, 1984 and is headquartered in Greensboro, NC. | Industrial Services |
| DVS Consulting LLC | |
| Biovision AG | |
| Summit Technology, Inc. | Health Technology |
| Cosmetic Laser Eye & Refractive Centers of America LLC | |
Black Light Surgical, Inc.
Black Light Surgical, Inc. Packaged SoftwareTechnology Services Black Light Surgical, Inc. has developed breakthrough technology to revolutionize medical imaging, based on years of research at Cedars-Sinai Medical Center. The company is based in Sunny Isles Beach, FL. The technology incorporates principles of auto-fluorescence lifetime and time-resolved auto-fluorescence spectroscopy, which can be used intra-operatively and is highly accurate in characterizing tissue without the need for dyes or drugs. The company's initial focus is on addressing the long-standing problem of breast cancer, where one-third of patients require a second or third procedure following breast conserving surgery (BCS) to fully remove the cancer. | Technology Services |
| Silq Technologies Corp. |
